The quarter report will show MDIN 24 mil annual revenues for just 2 products is real, and when the stemintense and stemextend revenues comes in it will be even bigger. I will not predict if the share price will go up or down because no one can, but I do know MDIN revenues will be a lot over 24 mil this fiscal year.
Market Data 
Markets 
AI
